Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07824206) titled 'Lumateperone Added to Antidepressant Therapy in Adults With Major Depressive Disorder Experiencing Emotional Blunting' on Sept. 11.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Future Options Research, LLC
Condition:
Blunted Emotion in Major Depressive Disorder
Intervention:
Drug: lumateparone 42 mg once daily
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: September 2026
Target Sample Size: 30
Countries of Recruitment:
United States
To know mo...